Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1053.72%
operating margin TTM
-771.16%
revenue TTM
3.50 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -13.86 |
| peg ratio | -0.14 |
| price to book ratio | 9.17 |
| price to sales ratio | 239.41 |
| enterprise value multiple | -32.55 |
| price fair value | 9.17 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -771.16% |
| pretax profit margin | -1027.55% |
| net profit margin | -1053.72% |
| return on assets | -53.07% |
| return on equity | -50.68% |
| return on capital employed | -43.8% |
liquidity ratios | |
|---|---|
| current ratio | 5.44 |
| quick ratio | 5.21 |
| cash ratio | 3.34 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 101.09 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 101.09 |
| receivables turnover | 3.61 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.08 |
| total debt to capitalization | 0.09 |
| interest coverage | -58.97 |
| cash flow to debt ratio | -5.73 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.81 |
| cash per share | 2.19 |
| operating cash flow per share | -1.78 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -5.73 |
| short term coverage ratios | -39.60 |
| capital expenditure coverage ratio | -65.16 |
Frequently Asked Questions
When was the last time Ambrx Biopharma Inc. (NYSE:AMAM) reported earnings?
Ambrx Biopharma Inc. (AMAM) published its most recent earnings results on 30-09-2023.
What is Ambrx Biopharma Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ambrx Biopharma Inc. (NYSE:AMAM)'s trailing twelve months ROE is -50.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ambrx Biopharma Inc. (AMAM) currently has a ROA of -53.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AMAM's net profit margin stand at?
AMAM reported a profit margin of -1053.72% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AMAM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.44 in the most recent quarter. The quick ratio stood at 5.21, with a Debt/Eq ratio of 0.10.